KCPG
CO

Kavar Capital Partners Group’s Global Cord Blood Corporation CO Stock Holding History

Kavar Capital Partners Group’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,757
Closed -$17K – 449
2018
Q2 		$17K Hold
1,757
– – 0.01% 276
2018
Q1 		$18K Buy
+1,757
New +$17.9K 0.01% 273

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
SAM
Silphium Asset Management London, United Kingdom $297M AUM 28.02% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kavar Capital Partners Group's CO Position: Q3 2018 in Review

Kavar Capital Partners Group sold out of Global Cord Blood Corporation (CO) in Q3 2018, closing a stake of 1,757 shares — an estimated $17K sold.

Kavar Capital Partners Group first reported a position in CO in Q1 2018 and held it in 2 quarters. The position peaked at $18K in Q1 2018. 43 funds tracked by Wall St. Rank hold CO as of Q3 2018.

  • Kavar Capital Partners Group reported no remaining Global Cord Blood Corporation position as of Q3 2018 after selling out during the quarter.
  • Kavar Capital Partners Group sold 1,757 Global Cord Blood Corporation shares in Q3 2018, an estimated $17K.
  • Kavar Capital Partners Group first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 2 quarters.
  • Kavar Capital Partners Group's Global Cord Blood Corporation position peaked at $18K in Q1 2018.
  • 43 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2018.

Based on Kavar Capital Partners Group's 13F filing for Q3 2018, filed 9 Nov 2018.